Technical Analysis for ANIK - Anika Therapeutics Inc.

Grade Last Price % Change Price Change
grade C 35.31 0.60% 0.21
ANIK closed up 0.6 percent on Friday, January 18, 2019, on 59 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Down Up Up
See historical ANIK trend table...

Date Alert Name Type % Chg
Jan 18 Overbought Stochastic Strength 0.00%
Jan 18 Up 3 Days in a Row Strength 0.00%
Jan 18 Up 4 Days in a Row Strength 0.00%
Jan 17 50 DMA Support Bullish 0.60%
Jan 17 Stochastic Reached Overbought Strength 0.60%
Jan 17 Outside Day Range Expansion 0.60%
Jan 17 Overbought Stochastic Strength 0.60%
Jan 17 Up 3 Days in a Row Strength 0.60%
Jan 16 50 DMA Support Bullish 2.38%
Jan 16 Narrow Range Bar Range Contraction 2.38%

Older signals for ANIK ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Anika Therapeutics, Inc., together with its subsidiaries, develops, manufactures, and commercializes therapeutic products for tissue protection, healing, and repair. Its products are based on hyaluronic acid (HA), a naturally occurring biocompatible polymer found in the body. The company's products include ORTHOVISC, ORTHOVISC mini, and MONOVISC for the treatment of osteoarthritis of the knee and various other joints; Hyalofast, a biodegradable support for human bone marrow mesenchymal stem cells that is used in connection with soft tissue regeneration; Hyalonect, a woven gauze used as a graft wrap; Hyaloss, HYAFF fibers used to mix blood/bone grafts to form a paste for bone regeneration; and Hyaloglide, an ACP gel used in tenolysis treatment. It also provides wound care products that comprise Hyalomatrix and Hyalofill, for treatment of complex wounds, such as burns and ulcers; and Hyalograft 3D and Laserskin scaffolds for use in connection with the regeneration of skin, as well as ELEVESS, an aesthetic dermatology product for facial wrinkles and scar remediation. In addition, the company offers AMVISC, AMVISC Plus, STAARVISC-II, Optivisc, AnikaVisc, and AnikaVisc Plus that are injectable HA products used as viscoelastic agents in ophthalmic surgical procedures, such as cataract extraction and intraocular lens implantation. Further, it provides Hyalobarrier, a post-operative adhesion barrier; INCERT, a HA product for the prevention of spinal post-surgical adhesions; and Merogel, a woven fleece nasal packing, as well as Merogel Injectable, a viscous hydrogel. Additionally, the company offers HYVISC, an injectable HA product used for the treatment of joint dysfunction in horses. Anika Therapeutics, Inc. markets its products directly, as well as through a network of distributors in the United States, Europe, and internationally. Anika Therapeutics, Inc. was founded in 1983 and is headquartered in Bedford, Massachusetts.
Is ANIK a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 69.81
52 Week Low 28.54
Average Volume 135,634
200-Day Moving Average 38.5209
50-Day Moving Average 33.7806
20-Day Moving Average 33.2375
10-Day Moving Average 34.383
Average True Range 1.5005
ADX 22.9
+DI 21.5869
-DI 12.1305
Chandelier Exit (Long, 3 ATRs ) 31.2385
Chandelier Exit (Short, 3 ATRs ) 34.0865
Upper Bollinger Band 36.5245
Lower Bollinger Band 29.9505
Percent B (%b) 0.82
BandWidth 19.778864
MACD Line 0.4377
MACD Signal Line 0.1495
MACD Histogram 0.2881
Fundamentals Value
Market Cap 517.58 Million
Num Shares 14.7 Million
EPS 2.25
Price-to-Earnings (P/E) Ratio 15.69
Price-to-Sales 7.22
Price-to-Book 3.29
PEG Ratio 2.68
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 36.99
Resistance 3 (R3) 36.95 36.34 36.71
Resistance 2 (R2) 36.34 35.92 36.37 36.62
Resistance 1 (R1) 35.83 35.65 36.09 35.87 36.52
Pivot Point 35.22 35.22 35.35 35.25 35.22
Support 1 (S1) 34.71 34.80 34.97 34.75 34.10
Support 2 (S2) 34.10 34.53 34.13 34.00
Support 3 (S3) 33.59 34.10 33.91
Support 4 (S4) 33.63